GLP-1RA plus SGLT2i combination therapy and liver fibrosis progression in MASLD with type 2 diabetes.

Hepatol Commun · 2026 · PMC13075898 · PMID 41974037

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A similar protective trend was observed in male patients (HR 0.77, 95% CI 0.59–1.01, p =0.058), aspirin users (HR 0.77, 95% CI 0.59–1.01, p =0.055), those aged ≥60 years (HR 0.79, 95% CI 0.59–1.04, p =0.095), and metformin or statin users, although these did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.